BTSG Valuation

Brightspring Health Services Inc

Add to Watchlist

Advanced Chart

24.080

+0.2(0.838%)1D

Overview
Forecast
Valuation
Earnings

BTSG Relative Valuation

BTSG's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BTSG is overvalued; if below, it's undervalued.

Historical Valuation

Brightspring Health Services Inc (BTSG) is now in the Undervalued zone, suggesting that its current forward PE ratio of 20.90 is considered Undervalued compared with the five-year average of 22.79. The fair price of Brightspring Health Services Inc (BTSG) is between 39.07 to 51.15 according to relative valuation methord. Compared to the current price of 23.98 USD , Brightspring Health Services Inc is Undervalued By 38.62%.

Relative Value

Fair Zone

39.07-51.15

Current Price：23.98

38.62%

Undervalued

20.90

Trailing

Forward

11.72

EV/EBITDA

Brightspring Health Services Inc. (BTSG) has a current EV/EBITDA of 11.72. The 5-year average EV/EBITDA is 9.82. The thresholds are as follows: Strongly Undervalued below 7.46, Undervalued between 7.46 and 8.64, Fairly Valued between 11.01 and 8.64, Overvalued between 11.01 and 12.19, and Strongly Overvalued above 12.19. The current Forward EV/EBITDA of 11.72 falls within the Overvalued range.

18.74

EV/EBIT

Brightspring Health Services Inc. (BTSG) has a current EV/EBIT of 18.74. The 5-year average EV/EBIT is 16.32. The thresholds are as follows: Strongly Undervalued below 12.12, Undervalued between 12.12 and 14.22, Fairly Valued between 18.42 and 14.22, Overvalued between 18.42 and 20.52, and Strongly Overvalued above 20.52. The current Forward EV/EBIT of 18.74 falls within the Overvalued range.

0.37

Brightspring Health Services Inc. (BTSG) has a current PS of 0.37. The 5-year average PS is 0.24. The thresholds are as follows: Strongly Undervalued below 0.11, Undervalued between 0.11 and 0.17, Fairly Valued between 0.30 and 0.17, Overvalued between 0.30 and 0.37, and Strongly Overvalued above 0.37. The current Forward PS of 0.37 falls within the Overvalued range.

12.20

P/OCF

Brightspring Health Services Inc. (BTSG) has a current P/OCF of 12.20. The 5-year average P/OCF is 9.44. The thresholds are as follows: Strongly Undervalued below 4.93, Undervalued between 4.93 and 7.19, Fairly Valued between 11.70 and 7.19, Overvalued between 11.70 and 13.96, and Strongly Overvalued above 13.96. The current Forward P/OCF of 12.20 falls within the Overvalued range.

15.34

P/FCF

Brightspring Health Services Inc. (BTSG) has a current P/FCF of 15.34. The 5-year average P/FCF is 14.38. The thresholds are as follows: Strongly Undervalued below 5.65, Undervalued between 5.65 and 10.02, Fairly Valued between 18.74 and 10.02, Overvalued between 18.74 and 23.11, and Strongly Overvalued above 23.11. The current Forward P/FCF of 15.34 falls within the Historic Trend Line -Fairly Valued range.

Brightspring Health Services Inc (BTSG) has a current Price-to-Book (P/B) ratio of 2.78. Compared to its 3-year average P/B ratio of 1.84 , the current P/B ratio is approximately 51.69% higher. Relative to its 5-year average P/B ratio of 1.84, the current P/B ratio is about 51.69% higher. Brightspring Health Services Inc (BTSG) has a Forward Free Cash Flow (FCF) yield of approximately 3.94%. Compared to its 3-year average FCF yield of 1.93%, the current FCF yield is approximately 104.58% lower. Relative to its 5-year average FCF yield of 1.93% , the current FCF yield is about 104.58% lower.

2.78

P/B

Median3y

1.84

Median5y

1.84

3.94

FCF Yield

Median3y

1.93

Median5y

1.93

Competitors Valuation Multiple

The average P/S ratio for BTSG's competitors is 2.49, providing a benchmark for relative valuation. Brightspring Health Services Inc Corp (BTSG) exhibits a P/S ratio of 0.37, which is -85.27% above the industry average. Given its robust revenue growth of 29.10%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

BTSG.O

Brightspring Health Services Inc

Option Care Health Inc

Concentra Group Holdings Parent Inc

LifeStance Health Group Inc

1.41

10.56%

2.19B

Performance Decomposition

Market capitalization of BTSG increased by 62.67% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 65.08 to 101.80.

The secondary factor is the Revenue Growth, contributed 29.10%to the performance.

Overall, the performance of BTSG in the past 1 year is driven by P/E Change. Which is more unsustainable.

29.10%

2.44B → 3.15B

Revenue Growth

-22.86%

0.35 → 0.27

Margin Expansion

56.43%

65.08 → 101.80

P/E Change

62.67%